Vitrolife AB (VTFN) Financial Statements
Vitrolife AB Financial Overview
Vitrolife AB's market cap is currently $1.43B. The company's EPS TTM is $-36.60; its P/E ratio is -3.15; and it has a dividend yield of 0.96%. Vitrolife AB is estimated to report earnings on January 28, 2027, and the estimated EPS forecast is $0.10. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.44B | $ 3.61B | $ 3.51B | $ 3.23B | $ 1.68B |
| Gross Profit | $ 2.00B | $ 2.13B | $ 1.98B | $ 1.79B | $ 1.05B |
| Operating Income | $ -4.83B | $ 783.00M | $ -3.59B | $ 654.00M | $ 435.00M |
| EBITDA | $ -4.39B | $ 1.23B | $ -3.19B | $ 977.00M | $ 579.60M |
| Net Income | $ -5.01B | $ 513.00M | $ -3.85B | $ 394.00M | $ 341.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 809.00M | $ 1.14B | $ 861.00M | $ 578.00M | $ 630.09M |
| Total Assets | $ 11.12B | $ 17.45B | $ 16.33B | $ 20.55B | $ 19.43B |
| Total Debt | $ 1.60B | $ 2.09B | $ 2.09B | $ 2.23B | $ 2.48B |
| Net Debt | $ 796.00M | $ 954.00M | $ 1.23B | $ 1.65B | $ 1.85B |
| Total Liabilities | $ 3.23B | $ 3.81B | $ 3.61B | $ 3.81B | $ 4.09B |
| Stockholders' Equity | $ 7.89B | $ 13.64B | $ 12.72B | $ 16.74B | $ 15.32B |
| Cash Flow | |||||
| Free Cash Flow | $ 460.00M | $ 815.00M | $ 638.00M | $ 549.00M | $ 321.86M |
| Operating Cash Flow | $ 635.00M | $ 907.00M | $ 757.00M | $ 636.00M | $ 384.31M |
| Investing Cash Flow | $ -302.00M | $ -377.00M | $ -124.00M | $ -144.00M | $ -6.52B |
| Financing Cash Flow | $ -553.00M | $ -286.00M | $ -300.00M | $ -582.00M | $ 5.75B |
Currency in SEK
